# Exercise-Associated Changes in Body Composition and Metabolic Biomarkers Following an Eight-Week Submaximal Exercise Program in Women Across Different BMI Categories and with Type 2 Diabetes

**Authors:** Kıvanç Buru, Vedat Çınar, Taner Akbulut, Mehdi Aslan, Meva Ceren Orgun, Fidan Çınar, Orhan Uluçay, Do-Youn Lee

PMC · DOI: 10.3390/biomedicines14020473 · Biomedicines · 2026-02-21

## TL;DR

An eight-week exercise program improved body composition and blood sugar control in women, but the effects on specific biomarkers varied depending on their weight and diabetes status.

## Contribution

The study shows how baseline BMI and diabetes status influence biomarker responses to exercise, despite consistent body composition improvements.

## Key findings

- Weight, fat mass, and visceral fat decreased significantly in overweight, obese, and T2DM groups.
- Irisin levels increased in all groups, indicating a universal myokine response to exercise.
- Biomarker responses like myonectin and HIF-1α varied significantly based on BMI and diabetes status.

## Abstract

Background/Objectives: This study evaluated exercise-induced changes in body composition and metabolic biomarkers in women across distinct BMI categories and individuals with Type 2 diabetes. Methods: In this quasi-experimental study, 40 sedentary women were stratified into five groups (n = 8): underweight, normal weight, overweight, obese, and T2DM. The rigorous eight-week supervised program utilized submaximal exercise at 70–85% heart rate reserve, calculated via the Karvonen method and monitored by telemetry. Assessments included anthropometric parameters (BMI, fat mass, visceral fat) and serum biomarkers (irisin, myonectin, HIF-1α, insulin, glucose). Fasting venous samples were collected at baseline and 72 h post-intervention to minimize acute effects, then analyzed using validated ELISA protocols. Statistical data were evaluated using parametric or non-parametric tests with significance set at p < 0.05. Results: Post-intervention, significant reductions in weight, fat mass, and visceral fat occurred in overweight, obese, and T2DM groups (p < 0.05). Muscle mass increased across all cohorts. Fasting insulin and glucose decreased significantly in all except the underweight group, with the most pronounced improvements in T2DM and obese participants. Serum irisin increased significantly across all groups (p < 0.05), indicating a universal exercise-induced myokine response. Conversely, myonectin levels decreased significantly only in the normal-weight group, while HIF-1α increased specifically in the T2DM cohort. These findings suggest that baseline BMI and metabolic status are critical determinants of exercise responsiveness, leading to heterogeneous biomarker patterns despite consistent improvements in body composition and basic glycemic regulation. Conclusions: An eight-week submaximal program effectively improves body composition and glycemic regulation, though specific biomarker responses are highly dependent on baseline BMI and metabolic status.

## Linked entities

- **Proteins:** FNDC5 (fibronectin type III domain containing 5), Erfe (erythroferrone), HIF1A (hypoxia inducible factor 1 subunit alpha), PIN (insulin precursor)
- **Diseases:** Type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HHIP (hedgehog interacting protein) [NCBI Gene 64399] {aka HIP}, C1QTNF5 (C1q and TNF related 5) [NCBI Gene 114902] {aka CTRP5, MFRP}, ERFE (erythroferrone) [NCBI Gene 151176] {aka C1QTNF15, CTRP15, FAM132B}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995] {aka FRCP2, irisin}
- **Diseases:** psychiatric disorders (MESH:D001523), DM (MESH:D003920), injury to (MESH:D014947), inflammatory (MESH:D007249), hematoma (MESH:D006406), syncope (MESH:D013575), hyperglycemia (MESH:D006943), mitochondrial dysfunction (MESH:D028361), metabolic dysregulation (MESH:D021081), metabolic disease (MESH:D008659), muscle mass (MESH:C536030), hemolysis (MESH:D006461), hypoxia (MESH:D000860), visceral adiposity (MESH:D007418), Obese (MESH:D009765), hypoxic (MESH:D002534), Overweight (MESH:D050177), myocardial infarction (MESH:D009203), cardiovascular complications (MESH:D002318), weight and fat mass loss (MESH:D015431), impaired insulin secretion (MESH:D007333), death (MESH:D003643), impaired glucose regulation (MESH:C565631), skeletal muscle hypertrophy (MESH:C536106), atherosclerosis (MESH:D050197), abdominal obesity (MESH:D056128), cardiovascular, respiratory, renal, hepatic, or endocrinological disorders (MESH:D018376), glucose intolerance (MESH:D018149), chronic (MESH:D002908), T2DM (MESH:D003924), Underweight (MESH:D013851), adiposity (MESH:D018205), abdominal adiposity (MESH:D000007), hypertrophic (MESH:D002312), Type 1 (MESH:D003922)
- **Chemicals:** catecholamine (MESH:D002395), fatty acid (MESH:D005227), carbohydrates (MESH:D002241), Curl5 (-), glucose (MESH:D005947), reactive oxygen species (MESH:D017382), lipid (MESH:D008055)
- **Species:** Meleagris gallopavo (common turkey, species) [taxon 9103], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937822/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12937822/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937822/full.md

---
Source: https://tomesphere.com/paper/PMC12937822